HOME >> MEDICINE >> NEWS
Drug trends among American teens

ANN ARBOR---With a few notable exceptions, drug use among American adolescents held steady in 1999, according to the latest results from the Monitoring the Future study, conducted at the University of Michigan Institute for Social Research (ISR). Reporting on the 25th national survey of high school seniors, and the ninth national survey of eighth- and 10th-graders, ISR research scientists Lloyd D. Johnston, Jerald G. Bachman, and Patrick M. O'Malley find that, in general, the changes in 1999 are modest.

"We are down some from the recent peak levels in overall illicit drug use by American teen-agers, which were reached in 1996 and 1997," states Johnston, "but not much of that improvement occurred this year. I am hopeful that this is just a pause in a longer-term decline. In fact, we saw such a pause in the 80s, in the middle of what turned out to be a continuing decline in drug use."

The investigators note that, after several years of steady increase, the annual prevalence rates for most drugs reached their recent peak levels in the mid 1990s---inhalants in 1995; hallucinogens, including LSD and PCP, in 1996; and marijuana and amphetamines in 1996 or 1997 (depending on the age of the students). The overall proportions reporting any illicit drug use in the prior year peaked among younger teens in 1996 and among older teens in 1997. In general, the usage statistics have been receding since then, at least until 1999.

Drugs which showed little change in use this year include marijuana, amphetamines, hallucinogens, tranquilizers, and heroin.

Monitoring the Future is conducted at the U-M Institute for Social Research (ISR) and is supported under a series of research grants from the National Institute on Drug Abuse, one of the National Institutes of Health in the U.S. Department of Health and Human Services.

One of the brightest spots in this year's story is that inhalant use appeared to continue its longer-term
'"/>

Contact: Diane Swanbrow
swanbrow@umich.edu
734-647-4416
University of Michigan
16-Dec-1999


Page: 1 2 3 4 5 6

Related medicine news :

1. Tracking trends in cochlear implant complications using a federal database
2. Changing trends in herbal supplement use
3. New figures highlight trends in drug and alcohol misuse
4. Study of trends in celiac disease
5. Different approaches required for monitoring suicide trends
6. Study identifies trends in self-referred imaging
7. Why trends in stroke death in 20th century appeared different to death from heart disease
8. CDC reports latest syphilis trends in United States
9. Prostate cancer incidence trends reveal extent of screening-related overdiagnosis
10. Recent trends in motorcycle fatalities
11. Study finds troubling trends in hepatitis C screening, diagnosis and referral

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Drug trends among American teens

(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... The Jerry ... at The ACE Club and Green Valley Country Club in Lafayette Hill, PA. Over ... raised more than $13.5 million for programs and services designed to support patients and ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... the release of version 5.2 of the FirstSpirit Content Management System with new ... With the new version of FirstSpirit, companies will be well on their way ...
(Date:9/1/2015)... ... September 01, 2015 , ... The FSH Society , the Massachusetts-based charity ... (FSHD), will be the beneficiary of a collection of fundraising events this fall. From ... of the FSH Society and further FSHD research. , The list of ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... and Qualification of Laboratory Instruments in accordance with GMP requirements“ , featuring Ed ... on October 6th, 2015 at 11:00 EDT (15:00 GMT). , Calibration, qualification, ...
(Date:9/1/2015)... York, NY (PRWEB) , ... September 01, 2015 ... ... that, to date, more than 1,500 investor-families have received permanent green cards (I-829 ... EB-5 projects. , The I-829 petition is the final step of the EB-5 ...
Breaking Medicine News(10 mins):Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2
(Date:9/1/2015)... , Sept. 1, 2015  Abbott (NYSE: ABT ... a multi-center, randomized trial comparing the safety and effectiveness ... ® , Abbott,s market-leading, permanent drug eluting stent. ... Japan and enrolled 400 people with ... disease. The results will be featured at a late-breaking ...
(Date:9/1/2015)... , Sept. 1, 2015  Valeant Pharmaceuticals International, ... today announced that its affiliate has entered into ... was granted an exclusive license to develop and ... IL-17 receptor monoclonal antibody in development for patients ... the agreement, Valeant will hold the exclusive rights ...
(Date:8/31/2015)... Pepperl+Fuchs, a world leader in process ... leading provider of HART protocol devices. The move ... its integrated solutions offerings and strengthen its position ... are pleased to add the MACTek WirelessHART product ... Bolin , Pepperl+Fuchs, executive vice president of the ...
Breaking Medicine Technology:Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 2Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 3Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 4Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4
Cached News: